InvestorsObserver is giving Insmed Incorporated (INSM) an Analyst Rating Rank of 73, meaning INSM is ranked higher by analysts than 73% of stocks. The average price target for INSM is $52.777 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating INSM a Strong Buy today. Find out what this means to you and get the rest of the rankings on INSM!
Why are Analyst Ratings Important?
You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.
InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.
What's Happening With Insmed Incorporated Stock Today?
Insmed Incorporated (INSM) stock is trading at $28.99 as of 10:36 AM on Thursday, Oct 28, a gain of $2.59, or 9.81% from the previous closing price of $26.40. The stock has traded between $26.80 and $29.21 so far today. Volume today is below average. So far 538,215 shares have traded compared to average volume of 881,371 shares.
Click Here to get the full Stock Report for Insmed Incorporated stock.